Understanding non-inferiority trials: an introduction
نویسندگان
چکیده
منابع مشابه
Understanding the null hypothesis (H0) in non-inferiority trials
I read with great interest the article by Zhou et al. [1] aiming to test whether a lactate-decreasing resuscitation protocol (lactate strategy), compared with central venous oxygen saturation-oriented resuscitation therapy (ScvO2 strategy), would decrease mortality among septic shock patients. It is not clear why the authors performed a noninferiority trial (NIT) whereas the primary objective o...
متن کاملAn Introduction to the Field Trials Methodology
The knowledge related to the methodology of the field trial study as a type of intervention studies, yet for many of our researchers is not fully understood. The aim of the current study was a better understanding of conducting this type of research. Field trial studies are done on healthy individuals and aim to prevent. These types of studies such as clinical trials are performed on both i...
متن کاملEquivalence and non inferiority trials
Many effective drugs, biologics and devices exist. Because of this, it is often considered unethical to undertake placebo controlled clinical trials to evaluate new treatments. Rather, randomized active control noninferiority trials have become the norm. These trials, however, are accompanied by serious issues including selecting an active comparator, identifying previously run active comparato...
متن کاملEquivalence and Non-inferiority Trials of CAM
For several reasons, the value of placebo-controlled trials has often been disputed (not only) in complementary/alternative medicine (CAM) (1). Many clinicians feel that giving placebos to suffering patients is unethical. In fact, the Declaration of Helsinki advocates placebo-controlled trials only for conditions for which no therapy of proven efficacy exists (2). Other frequently cited reasons...
متن کاملBio-creep in non-inferiority clinical trials.
After a non-inferiority clinical trial, a new therapy may be accepted as effective, even if its treatment effect is slightly smaller than the current standard. It is therefore possible that, after a series of trials where the new therapy is slightly worse than the preceding drugs, an ineffective or harmful therapy might be incorrectly declared efficacious; this is known as 'bio-creep'. Several ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Anesthesia/Journal canadien d'anesthésie
سال: 2014
ISSN: 0832-610X,1496-8975
DOI: 10.1007/s12630-014-0132-y